Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays - Nanoscale (RSC Publishing)
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross- reactivity of nCoV with SARS-CoV WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross- reactivity of nCoV with SARS-CoV](https://cdn.who.int/media/images/default-source/thumbnails-global/prospects-for-evaluating-cross-reactivity-of-ncov-with-sars-cov2c00696e-a00a-41a5-ba4e-2fcd7ba6eb93.tmb-479v.png?sfvrsn=b9e07497_2)
WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross- reactivity of nCoV with SARS-CoV
![Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K. Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.](https://journals.sagepub.com/cms/10.1177/0192623310382559/asset/images/large/10.1177_0192623310382559-fig3.jpeg)
Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.
![Cross-reactivity profiles of legumes and tree nuts using the xMAP® multiplex food allergen detection assay | Analytical and Bioanalytical Chemistry Cross-reactivity profiles of legumes and tree nuts using the xMAP® multiplex food allergen detection assay | Analytical and Bioanalytical Chemistry](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00216-017-0528-y/MediaObjects/216_2017_528_Figa_HTML.gif)
Cross-reactivity profiles of legumes and tree nuts using the xMAP® multiplex food allergen detection assay | Analytical and Bioanalytical Chemistry
![SIDP on X: "@SIDPharm member @not_that_CDC and team found that implementation of a β-lactam cross-reactivity chart combined with enhanced #allergy assessment was associated with ⬆️ utilization of β-lactams in patients with PNA SIDP on X: "@SIDPharm member @not_that_CDC and team found that implementation of a β-lactam cross-reactivity chart combined with enhanced #allergy assessment was associated with ⬆️ utilization of β-lactams in patients with PNA](https://pbs.twimg.com/media/FEz67QrXMAsPHfB.jpg:large)
SIDP on X: "@SIDPharm member @not_that_CDC and team found that implementation of a β-lactam cross-reactivity chart combined with enhanced #allergy assessment was associated with ⬆️ utilization of β-lactams in patients with PNA
![Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K. Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.](https://journals.sagepub.com/cms/10.1177/0192623310382559/asset/images/large/10.1177_0192623310382559-fig2.jpeg)
Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.
![Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1367593113002317-gr1.jpg)
Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect
![JCI Insight - Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2 JCI Insight - Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2](https://df6sxcketz7bb.cloudfront.net/manuscripts/158000/158308/medium/jci.insight.158308.ga.jpg)
JCI Insight - Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2
![Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine](https://www.genomics.sinica.edu.tw/media/k2/items/cache/1e6006496cec394e7da669516f53f970_XL.jpg?t=20230530_073838)
Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Frontiers | The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer Frontiers | The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer](https://www.frontiersin.org/files/Articles/1212546/fimmu-14-1212546-HTML-r2/image_m/fimmu-14-1212546-g001.jpg)